Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06447597 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT06447597 · ClinicalTrials.gov record · last posted 2026-08-14

A Clinical Study of B007 in the Treatment of Generalized Myasthenia Gravis.

StatusRecruiting
PhasePhase 2/3
Started2024-07-01
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
The purpose of this study is to evaluate the efficacy and safety of B007 in subjects with generalized myasthenia gravis.

Protocol amendment history 2 changes detected by DataLookout

2026-08-15
Primary completion pushed: 2026-06-30 → 2026-12-30
2026-08-15
Completion pushed: 2026-06-30 → 2026-12-30
Trial Details
NCT Number NCT06447597
Lead Sponsor Shanghai Jiaolian Drug Research and Development Co., Ltd
Collaborators: Shanghai Pharmaceuticals Holding Co., Ltd
Conditions Generalized Myasthenia Gravis
Enrollment 104 participants
Start Date 2024-07-01
Primary Completion 2026-12-30 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-14